Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
Contact Us |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages
Start Over | Back to Previous Screen
Dextrose 5% Injection
Status: Currently in Shortage
»Date first posted:
02/14/2022
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Other; Pediatric
B. Braun Medical Inc. (New 02/16/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 5% 500 mL Excel Bag L5101 (NDC 0264-7510-10) | Product on allocation for contracted customers | Other | |
| 5% 1000 mL Excel Bag L5100 (NDC 0264-7510-00) | Product on allocation for contracted customers | Other | |
| 5% 250 mL Excel Bag L5102 (NDC 0264-7510-20) | Product on allocation for contracted customers | Other | |
| 5% 100 mL PAB Bag S5104-5264 (NDC 0264-1510-32) | Product available | ||
| 5% 50 mL PAB Bag S5104-5364 (NDC 0264-1510-31) | Product available | ||
| 10% 1000 mL Excel Bag L5200 (NDC 0264-7520-00) | Product available | ||
| 10% 500 mL Excel Bag L5201 (NDC 0264-7520-10) | Product available | ||
| 10% 250 mL Excel Bag L5202 (NDC 0264-7520-20) | Product on allocation for contracted customers | Other |
Baxter Healthcare (Reverified 03/01/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 5% Dextrose Injection, USP, 25 mL VIAFLEX Plastic Container Quad Pack, Product Code 2B0080, (NDC 0338-0017-10) | Available | ||
| 5% Dextrose Injection, USP, 50 mL VIAFLEX Plastic Container, Product Code 2B0086, (NDC 0338-0017-41) | Available | ||
| 5% Dextrose Injection, USP, 50 mL VIAFLEX Plastic Container, Quad Pack, Product Code 2B0081, (NDC 0338-0017-11) | Available | ||
| 5% Dextrose Injection, USP, 50 mL VIAFLEX Plastic Container, Multi Pack, Product Code 2B0088, (NDC 0338-0017-31) | Available | ||
| 5% Dextrose Injection, USP, 100 mL VIAFLEX Plastic Container, Product Code 2B0087, (NDC 0338-0017-48) | Available | ||
| 5% Dextrose Injection, USP, 100 mL VIAFLEX Plastic Container, Quad Pack, Product Code 2B0082, (NDC 0338-0017-18) | Available | ||
| 5% Dextrose Injection, USP, 100 mL VIAFLEX Plastic Container, Multi Pack, Product Code 2B0089, (NDC 0338-0017-38) | Available | ||
| 5% Dextrose Injection, USP, 50 mL MINI-BAG Plus Container. Quad Pack, Product Code 2B0040, (NDC 0338-0551-11) | Available | ||
| 5% Dextrose Injection, USP, 50 mL MINI-BAG Plus Container, Product Code EZPB0040, (NDC 0338-9143-30) | Available on allocation | Demand increase | |
| 5% Dextrose Injection, USP, 100 mL MINI-BAG Plus Container, Product Code EZPB0041, (NDC 0338-9147-30) | Available on allocation | ||
| 5% Dextrose Injection, USP, 100 mL MINI-BAG Plus Container, Product Code 2B0041, (NDC 0338-0551-18) | Available | Demand increase | |
| 5% Dextrose Injection, USP, 1000 mL VIAFLO Plastic Container, Product Code UE0064D, (NDC 0338-0070-10) | Available | ||
| 5% Dextrose Injection, USP, 250 mL VIAFLEX Plastic Container, Product Code 2B0062Q, (NDC 0338-0017-02) | Available | ||
| 5% Dextrose Injection, USP, 250 mL VIAFLO Plastic Container, Product Code UE0062D, (NDC 0338-0062-30) | Limited Supply, Recovery Q2 | Third-party Supplier Issue | |
| 5% Dextrose Injection, USP, 500 mL VIAFLEX Plastic Container, Product Code 2B0063Q, (NDC 0338-0017-03) | Available | ||
| 5% Dextrose Injection, USP, 500 mL VIAFLO Plastic Container, Product Code UE0063D, (NDC 0338-0066-20) | Limited supply; Recovery Q2 | Third-party Supplier Issue |
Fresenius Kabi USA, LLC (Revised 03/10/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 5% Dextrose Injection, Single dose freeflex bag, (50 mg per mL), (5 grams per 100 mL) (NDC 63323-624-61) | Backordered. Next release March 2023. | Check wholesaler inventory | Increase in Demand |
| 5% Dextrose Injection, Single dose freeflex bag, (50 mg per mL), (12.5 grams per 250 mL) (NDC 63323-624-74) | Backordered. Next release March 2023. | Check wholesaler inventory | Increase in Demand |
| 5% Dextrose Injection, Single dose freeflex bag, (50 mg per mL), (25 grams per 500 mL) (NDC 63323-624-75) | Backordered. Next release March 2023. | Increase in Demand | |
| 5% Dextrose Injection, Single dose freeflex bag, (50 mg per mL), (50 grams per 1,000 mL) (NDC 63323-624-10) | Available | Check wholesaler inventory | Increase in Demand |
| 5% Dextrose Injection, Single dose freeflex bag, (50 mg per mL), (2.5 grams per 50 mL) (NDC 63323-624-50) | Backordered. Next release March 2023. | Increase in Demand |
Hospira, Inc., a Pfizer company (Reverified 03/17/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 50 mL; ADD-Vantage Flexible Container (Case of 50)(NDC 0409-7100-66) | Available | Other | |
| 100 mL; ADD-Vantage Flexible Container (Case of 50)(NDC 0409-7100-67) | Available | Other | |
| 250 mL; ADD-Vantage Flexible Container (Case of 24)(NDC 0409-7100-02) | Available | Other |
ICU Medical, Inc. (Reverified 03/16/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 5% Dextrose Injection, USP, 250 mL (Legacy Hospira NDC 0409-7922-02) (ICU Medical NDC 0990-7922-02) | Available | ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. | |
| 5% Dextrose Injection, USP, 150 mL (Legacy Hospira NDC 0409-7922-61) (ICU Medical NDC 0990-7922-61) | Available | ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. | |
| 5% Dextrose Injection, USP, 50 mL (Legacy Hospira NDC 0409-7923-13) (ICU Medical NDC 0990-7923-13) | Available | ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. | |
| 5% Dextrose Injection, USP, 25 mL 4-1 (Legacy Hospira NDC 0409-7923-20) (ICU Medical NDC 0990-7923-20) | Available | ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. | |
| 5% Dextrose Injection, USP, 100 mL (Legacy Hospira NDC 0409-7923-23) (ICU Medical NDC 0990-7923-23) | Available | ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. | Demand increase for the drug |
| 5% Dextrose Injection, USP, 50 mL 4-1 (Legacy Hospira NDC 0409-7923-36) (ICU Medical NDC 0990-7923-36) | Available | ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. | |
| 5% Dextrose Injection, USP, 100 mL 4-1 (Legacy Hospira NDC 0409-7923-37) (ICU Medical NDC 0990-7923-37) | Available | ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. | |
| 5% Dextrose Injection, USP, 500 mL (Legacy Hospira NDC 0409-7922-03) (ICU Medical NDC 0990-7922-03) | Available | ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. | |
| 5% Dextrose Injection, USP, 500 mL (Legacy Hospira NDC 0409-7922-55) (ICU Medical NDC 0990-7922-55) | Available | ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. | |
| 5% Dextrose Injection, USP, 1000 mL (Legacy Hospira NDC 0409-7922-09) (ICU Medical NDC 0990-7922-09) | Available | ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. |